The Frequency Of Hematological Abnormalities in Children (Age 1 Month To 12 Years) Presenting With Sars-Cov-2 Infection At Shifa International Hospital

The Frequency Of Hematological Abnormalities in Children (Age 1 Month To 12 Years) Presenting With Sars-Cov-2 Infection At Shifa International Hospital

Objective: To determine the frequency of haematological abnormalities in pediatric patients presenting with COVID-19 infection. Methods: A Cross-Sectional analytical study was conducted at the paediatric department of Shifa International Hospital Islamabad, over a period of six months from Decemb...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sidra Tul Muntaha, Hammad Ayaz, Huma Mahmood, Afifa Kulsoom, Muhammad Tayyab, Arslan Farooq
Format:	Article
Language:	English
Published:	Rawalpindi Medical University 2024-03-01
Series:	Journal of Rawalpindi Medical College
Online Access:	https://www.journalrmc.com/index.php/JRMC/article/view/2424
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use Of Anti-Epileptics For Seizure Prophylaxis After Traumatic Brain Injury In The Pediatric Population
by: Aroosh Khan, et al.
Published: (2024-12-01)

Al Shifa Home: A Model for the Rehabilitation of ISIS Combatants
by: Bulama Bukarti, et al.
Published: (2025-06-01)

Biochar and carbon-negative technologies: exploring opportunities for climate change mitigation
by: Muhammad Ayaz, et al.
Published: (2025-01-01)

SHIFA: SBERT-Based Healthcare Information Focused Arabic Question Answering
by: Rahaf Alruwaithi, et al.
Published: (2025-01-01)

The perception of shared governance among nurses at Dar Al Shifa Hospital in Kuwait in 2024
by: Ahmad Fawzi Aldmour, et al.
Published: (2024-12-01)

Exploring Pragmatic Markers in The Reluctant Fundamentalist: A Corpus-Based Analysis of Mohsin Hamid's Narrative Techniques
by: Sidra-Tul-Muntaha, et al.
Published: (2025-03-01)

MARKETING METHODS OF INCREASE OF PALESTINE MEDICAL INSTITUTIONS EFFICIENCY: CASE STUDY OF AL-SHIFA HOSPITAL
by: Nedal K. TOMAN
Published: (2010-12-01)

Effects of Social Barriers on the Contraceptive Use among Males and Females in PNS-SHIFA Hospital Karachi
by: Hunza Jawed, et al.
Published: (2016-09-01)

Self-Medication Practice Among the General Community Of An Urban Squatter Settlement Near PNS Shifa Karachi
by: Amna Younus, et al.
Published: (2013-06-01)

Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease
by: Sally J. Lawrence, et al.
Published: (2025-05-01)

Neutralizing-antibody response to SARS-CoV-2 for 12 months after the COVID-19 workplace outbreaks in Japan.
by: Azumi Ishizaki, et al.
Published: (2022-01-01)

Randomised Trial: Adrenaline & Dexamethasone Vs. Adrenaline In Children With Bronchiolitis
by: Sidra Choudhary, et al.
Published: (2024-12-01)

High-efficiency broadband grating out-coupler for thick silicon waveguides with a tuned SiGe layer
by: Muntaha Sidra Tul, et al.
Published: (2025-01-01)

The Comparison Of Outcome In Engaged Versus Unengaged Fetal Heads In Primigravida
by: Sadaf Asma, et al.
Published: (2023-12-01)

SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics
by: Nadia Siles Alvarado, et al.
Published: (2025-05-01)

Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long COVID
by: Tamara Cruz, et al.
Published: (2025-04-01)

Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2023-02-01)

Tracing the Sars-CoV-2 Impact: The First Month in Switzerland
by: Joseph Molloy, et al.
Published: (2020-05-01)

Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection
by: Zoha Khan, et al.
Published: (2025-05-01)

To Compare Serum Procalcitonin And CRP As Markers Of Neonatal Sepsis
by: Rafiq Ahmad, et al.
Published: (2024-03-01)

Predicting Long-Term Health-Related Quality of Life in Individuals With Prior SARS-CoV-2 Infection: A 12-Month Prospective Study
by: Ali A. Weinstein, et al.
Published: (2025-05-01)

Efficacy of vaccination during pregnancy in reducing the risk of SARS-CoV-2 infection in infants younger than 12 months. Puglia (Italy), 2021–23
by: Cesare De Virgilio Suglia, et al.
Published: (2024-12-01)

Lipid profile changes after the acute COVID-19 period. Sub-analysis of the International Registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2024-04-01)

Hematological and histopathological effects of xenoestrogen (Bisphenol A) on liver and kidney functions of Mozambique tilapia fish (Oreochromis mossambicus)
by: Sidra Waris, et al.
Published: (2023-05-01)

SARS-CoV-2 Variants and Their Impact on Pediatric COVID-19: Clinical Manifestations and Hematological Profiles
by: Konstantinos Paris Trempelis, et al.
Published: (2025-02-01)

Effects of Vitamin B12 deficiency on hematological parameters
by: GÜLALİ AKTAŞ, et al.
Published: (2014-08-01)

Differential DNA methylation 7 months after SARS-CoV-2 infection
by: Peizhen Hong, et al.
Published: (2025-04-01)

Data on Brazilian Powdered Milk Formulations for Infants of Various Age Groups: 0–6 Months, 6–12 Months, and 12–36 Months
by: Francisco José Mendes dos Reis, et al.
Published: (2025-07-01)

A systematic review of neurological symptoms and brain abnormalities in SARS-CoV-2 infections
by: Daniel Montoya, et al.
Published: (2023-08-01)

Hybrid Blockchain-Based Multi-Operator Resource Sharing and SLA Management
by: Sidra Tul Muntaha, et al.
Published: (2025-01-01)

Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2023-05-01)

Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study
by: Flavia Petrucci, et al.
Published: (2025-02-01)

The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases
by: Eva Tiselius, et al.
Published: (2025-07-01)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
by: Tjalf Ziemssen, et al.
Published: (2024-12-01)

Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months
by: Qin Luo, et al.
Published: (2025-05-01)

Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems
by: LR Tilova, et al.
Published: (2017-04-01)

Associations of maternal diet with infant adiposity at birth, 6 months and 12 months
by: Brian Neelon, et al.
Published: (2019-09-01)

Retrospective analysis of hospitalization rates in patients with schizophrenia 12 months before and 12 months after the switch on once-monthly long-acting injectable paliperidone palmitate
by: Totić-Poznanović Sanja, et al.
Published: (2023-01-01)

Post‐COVID immunity in patients with solid tumor or hematological malignancies treated with SARS‐CoV‐2 monoclonal antibodies
by: Gilberto Sabino‐Santos, et al.
Published: (2024-12-01)

Protamine 2 deficiency results in Septin 12 abnormalities
by: Ondrej Sanovec, et al.
Published: (2024-10-01)